Anebulo Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview

Anebulo Pharmaceuticals

07/02/2025 11:16

* Anebulo Pharmaceuticals Inc  ANEB.OQ   ANEB.O  is expected
to show no change in quarterly revenue when it reports 
results on February 11 (estimated) for the period ending
December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Anebulo Pharmaceuticals
Inc is
for a loss of 8 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Anebulo
Pharmaceuticals Inc is $6.00​, above​ its last closing price
of $1.54. ​​​

This summary was machine generated February 7 at 11:16 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)